Article PDF
References
Lavie, A. et al. The bottleneck in AZT activation. Nature Med. 3, 922–924 (1997).
Balzarini, J. et al. The in vitro and in vivo anti-retro-virus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxy-cytidine are highly dependent on the cell species. Biochem. Pharmacol. 37, 897–903 (1988).
Balzarini, J., Herdewijn, P. & De Clercq, E. Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264, 6127–6133 (1989).
Frick, L.W. et al. Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem. Biophys. Res. Comm. 154, 124–129 (1988).
Guettari, N., Loubiere, L., Brisson, E. & Klatzmann, D. Use of Herpes-simplex Virus Thymidine Kinase to Imporve the Antiviral Activity of Zidovudine. Virology 235, 398–405 (1997).
Meier, C., Habel, L., Laux, W., Declercq, E., & Balzarini, J. Homo Dinucleoside-alpha-hydroxyphosphonate Diesters as Prodrugs of the Antiviral Nucleoside Analogues 2′,3′-Dideoxythymidine and 3′-Azido-2′,3′Dideoxythymidine. Nudeosides & Nudeotides 14, 759–762 (1995).
Lavie, A. et al. Crystal Structure of Yeast Thymidylate Kinase Complexed with the Bisubstrate Inhibitor P1-(5′-Adenosyl)P5-(5′-Thymidyl)Pentaphosphate (TP5A) at 2.0 Å Resolution: Implications for Catalysis and AZT Activation Biochem. In the press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balzarini, J., Degrève, B. & De Clercq, E. Improving AZT efficacy. Nat Med 4, 132 (1998). https://doi.org/10.1038/nm0298-132a
Issue Date:
DOI: https://doi.org/10.1038/nm0298-132a
This article is cited by
-
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
Nature Medicine (1999)
-
Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling
Nature Biotechnology (1999)